乌干达坎帕拉孕妇和哺乳期妇女在B组链球菌II期临床试验期间的顾虑:一项定性研究
在乌干达坎帕拉对参加B组链球菌临床试验的孕妇进行深度访谈、对哺乳期妇女开展焦点小组讨论,探讨其接种犹豫原因。所有妇女均因担心疫苗副作用而对参加试验犹豫,其他顾虑包括缺乏孕产妇疫苗知识、社区谣言与污名化以及需遵循研究程序。作者认为需与家庭和社区利益相关方沟通。
要点
- 所有受访妇女均因担心疫苗可能副作用而对参加试验犹豫。
- 其他顾虑包括缺乏孕产妇疫苗知识、社区谣言与污名化、需遵循研究程序。
- 部分妇女担心男性伴侣对自己参加试验的看法,因使用试验疫苗意味着替胎儿做决定。
核心结论
- 孕妇参与孕产妇免疫临床试验需要与家庭和社区利益相关方(包括地方领导和卫生工作者)沟通,以确保人们了解孕产妇疫苗是什么以及为何需要孕妇参与的试验。
研究设计与样本
- 对参加B组链球菌临床试验的孕妇进行深度访谈,对哺乳期妇女开展焦点小组讨论。
- 研究期间从随访名单中随机选取18-39岁妇女,数据采用主题分析法分析。
主要发现
- 所有妇女在加入试验前均因担心疫苗可能副作用而对参加试验犹豫。
- 缺乏孕产妇疫苗知识、社区谣言与污名化以及需遵循研究程序是其他顾虑。
- 部分妇女担心男性伴侣对其参加试验的看法,因为使用试验疫苗意味着替胎儿做决定。
临床怎么用
- 作者认为孕妇参与孕产妇免疫临床试验需要与家庭和社区利益相关方(包括地方领导和卫生工作者)沟通,以确保人们了解孕产妇疫苗是什么以及为何需要孕妇参与的试验。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite evidence that maternal vaccines can contribute to reduction of neonatal infections, vaccine hesitancy is a challenge in many low- and middle-income countries like Uganda. We conducted in-depth interviews with pregnant women and focus group discussions with breastfeeding women who were part of a Group B Streptococcus (GBS) clinical trial. We explored the women's concerns about vaccination and their reasons for being hesitant to take vaccines before they joined the trial. Women aged 18-39 were randomly selected from follow-up lists during the study period. Data were analysed thematically. All the women had been hesitant about joining the trial because of fear of possible vaccine side effects. A lack of knowledge on maternal vaccines, rumours and stigma in the community as well the need to follow study procedures were other concerns. Several women were concerned about their male partner view of their trial participation because using a trial vaccine meant taking a decision on behalf of the foetus. Pregnant women's involvement in clinical trials of maternal immunisation requires engagement with their families and community stakeholders, including local leaders and health workers, to ensure people understand what maternal vaccines are and why trials with pregnant women are required.
引用
- Ssali A, Nalubega P, Namugumya R, et al. Pregnant and breastfeeding women concerns during a group B Streptococcus phase ll clinical trial: A qualitative study in Kampala, Uganda. Vaccine. 2025. PMID: 40782462. doi:10.1016/j.vaccine.2025.127592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。